ProImmune Inc. Introduces ProM2™ Human Class II MHC Monomer Reagents To Study CD4+ T Cell Immune Responses

Enabling proven tetramer analysis for detecting single antigen-specific T cells

29 January 2015 – ProImmune, a leader in services for understanding and managing adaptive immune responses, announced today the introduction of ProM2TM, a range of Human Class II MHC monomer reagents for tetramer analyses in the study of CD4+ T cell immune responses. ProImmune’s offering represents the broadest choice of ready to order catalog and custom items in this field and will enable research into CD4+ T cell responses in a variety of disease areas including cancer, infectious diseases, autoimmunity and transplantation.

CD4+ T cell responses are at the heart of steering the adaptive immune system directing both cytotoxic T cell responses and antibody responses mediated by B cells. ProM2 Class II MHC Monomers are pre-biotinylated and can be readily made into MHC tetramers that allow the detection of single antigen-specific CD4+T cells accurately by flow cytometry. Class II tetramers made from ProM2 monomers can also be used to separate cells for culture, expansion, and further study.

“The concept of Class II MHC tetramer reagents has been in the public domain for nearly two decades and yet the availability of appropriate class II tetramer reagents is still limited, especially as catalog items,” commented Nikolai Schwabe, CEO of ProImmune. “This is due in part to problems of synthesizing recombinant Class II MHC molecules. We are delighted that our new offering of reagents addresses this and gives researchers access to the broadest range of class II reagents for studying immune responses in many important disease areas.”

ProM2 Class II MHC Monomer reagents are supported by ProImmune’s expert customer service and application support, helping new users in particular to establish and optimize robust protocols in their own laboratories.

The class II reagent offering complements ProImmune’s existing extensive range of services for evaluating CD4+ T cell responses, including ProImmune REVEAL® MHC peptide binding assays, CD4+ T cell and DC T cell proliferation assays and standard immune monitoring services through ELISPOT and flow cytometry based assays.

For more information on ProM2 reagents and their availability*, or to place an order, please visit: www.proimmune.com, email enquiries@proimmune.com, or call + 1 888 505 7765 in the United States or + 44 870 042 7279 in other countries. * ProM2 reagents are not available initially in the UK, Germany, France, Canada and Japan.

-ENDS-

Notes to Editors:

About ProImmune - www.proimmune.com

ProImmune’s mission is to be a partner of choice for understanding and managing adaptive immune responses. It does this by offering unique solutions for preclinical and clinical immunology research, including a comprehensive and integrated antigen characterization and immunogenicity testing platform, and products and services for tracking antigen-specific immune responses with state-of-the-art ELISpot and flow cytometry techniques. ProImmune is committed to helping researcher’s achieve success through product innovation, responsive service and focused application support, saving time and money, and reducing risk.

For more information, please contact

At ProImmune:
Jeremy Fry
Tel: +44 (0) 870 042 7279
Email: enquiries@proimmune.com
Media enquiries:
Sarah Jeffery
Zyme Communications Ltd
Tel: +44 (0) 7771 730 919
Email: sarah.jeffery@zymecommunications.com

Help employers find you! Check out all the jobs and post your resume.

Back to news